Lanthio Pharma's Grant - III Round

Lanthio Pharma raised a round of funding on May 21, 2014. Investors include Netherlands Enterprise Agency.

Lanthio Pharma is a biopharmaceutical company committed to developing and commercializing therapeutic peptides against difficult to target receptors (e.g. GPCRs). With its proprietary LanthioPep techn…

Articles about Lanthio Pharma's Grant - III Round: